Literature DB >> 33489462

Correlation of GLUT1 and GLUT4 with prognosis of patients with hypothyroidism and cardiac insufficiency.

Xiaocheng Song1, Yudan Zhu1, Zhi Dai2, Guimei Ling3, Hongqin Tang4, Qiannan Xu4, Tinglin Guo1.   

Abstract

OBJECTIVE: Hypothyroidism is a disease with symptoms of collective metabolic dysfunction and systemic dysfunction due to the lack of serum thyroid hormones caused by various reasons. GLUT4 is over-expressed in monocytes of patients with hyperthyroidism, there are also studies suggesting that there is a certain regulatory relationship of GLUT1 and GLUT4 with thyroid function. This study is aimed to explore the correlation of glucose transporter 1 (GLUT1) and GLUT4 with prognosis of patients with hypothyroidism and cardiac insufficiency.
METHODS: From July 2016 to October 2019, totally 116 patients with cardiac insufficiency complicated with subclinical hypothyroidism treated in our hospital were enrolled in the research group (RG), and 110 patients with cardiac insufficiency but normal thyroid function were enrolled in the control group (CG). Serum GLUT1, GLUT4, free triiodothyronine (FT3), free thyroxine (FT4) and thyroid stimulating hormone (TSH) were detected, and the correlation between them was analyzed. Then the predictive value and risk factors of GLUT1 and GLUT4 for poor prognosis of hypothyroidism complicated with cardiac insufficiency were analyzed.
RESULTS: The expression levels of GLUT1, GLUT4, FT3 and FT4 in serum of patients in RG was notably lower than that in CG, and TSH expression was remarkably higher than those in CG (P<0.05). In RG, GLUT1 and GLUT4 expression levels were positively correlated with FT3 and FT4 expression (P<0.05), but negatively correlated with TSH expression (P<0.05). ROC of GLUT1 and GLUT4 in RG in predicting poor prognosis of patients was over 0.8. Low expression of GLUT1 and GLUT4 and diabetes were independent risk factors for poor prognosis in patients with hypothyroidism complicated with cardiac insufficiency.
CONCLUSION: GLUT1 and GLUT4 expression levels were significantly decreased in serum of patients with hypothyroidism complicated with cardiac insufficiency. Both of them have high predictive value for poor prognosis of patients, and are independent risk factors for poor prognosis of patients. AJCD
Copyright © 2020.

Entities:  

Keywords:  GLUT1; GLUT4; cardiac insufficiency; hypothyroidism; prognosis prediction

Year:  2020        PMID: 33489462      PMCID: PMC7811914     

Source DB:  PubMed          Journal:  Am J Cardiovasc Dis        ISSN: 2160-200X


  26 in total

1.  Free triiodothyronine, not thyroid stimulating hormone, should be focused on for risk stratification in acute decompensated heart failure.

Authors:  Takuya Kishi
Journal:  J Cardiol       Date:  2015-06-06       Impact factor: 3.159

2.  Edaravone ameliorates experimental autoimmune thyroiditis in rats through HO-1-dependent STAT3/PI3K/Akt pathway.

Authors:  Hong Li; Jie Min; Xiaoming Mao; Xueyang Wang; Yucheng Yang; Yuting Chen
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

3.  Subclinical hypothyroidism and the risk of coronary heart disease and mortality.

Authors:  Nicolas Rodondi; Wendy P J den Elzen; Douglas C Bauer; Anne R Cappola; Salman Razvi; John P Walsh; Bjørn O Asvold; Giorgio Iervasi; Misa Imaizumi; Tinh-Hai Collet; Alexandra Bremner; Patrick Maisonneuve; José A Sgarbi; Kay-Tee Khaw; Mark P J Vanderpump; Anne B Newman; Jacques Cornuz; Jayne A Franklyn; Rudi G J Westendorp; Eric Vittinghoff; Jacobijn Gussekloo
Journal:  JAMA       Date:  2010-09-22       Impact factor: 56.272

4.  Low-flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo.

Authors:  L H Young; Y Renfu; R Russell; X Hu; M Caplan; J Ren; G I Shulman; A J Sinusas
Journal:  Circulation       Date:  1997-01-21       Impact factor: 29.690

5.  IGF-I increases the recruitment of GLUT4 and GLUT3 glucose transporters on cell surface in hyperthyroidism.

Authors:  George Dimitriadis; Eirini Maratou; Eleni Boutati; Anastasios Kollias; Katerina Tsegka; Maria Alevizaki; Melpomeni Peppa; Sotirios A Raptis; Dimitrios J Hadjidakis
Journal:  Eur J Endocrinol       Date:  2008-03       Impact factor: 6.664

Review 6.  The current debate over treatment of subclinical hypothyroidism to prevent cardiovascular complications.

Authors:  Steven G Chrysant
Journal:  Int J Clin Pract       Date:  2020-05-03       Impact factor: 2.503

7.  α1A-Adrenergic receptor prevents cardiac ischemic damage through PKCδ/GLUT1/4-mediated glucose uptake.

Authors:  Ting Shi; Robert S Papay; Dianne M Perez
Journal:  J Recept Signal Transduct Res       Date:  2015-09-29       Impact factor: 2.092

8.  Diabetes Alters the Expression and Translocation of the Insulin-Sensitive Glucose Transporters 4 and 8 in the Atria.

Authors:  Zahra Maria; Allison R Campolo; Veronique A Lacombe
Journal:  PLoS One       Date:  2015-12-31       Impact factor: 3.240

9.  Subclinical Hypothyroidism Affects the Long-Term Outcomes of Patients Who Undergo Coronary Artery Bypass Grafting Surgery but Not Heart Valve Surgery.

Authors:  Hana Kim; Sung Hye Kong; Jae Hoon Moon; Sang Yoon Kim; Kay-Hyun Park; Jun Sung Kim; Joong Haeng Choh; Young Joo Park; Cheong Lim
Journal:  Endocrinol Metab (Seoul)       Date:  2020-06-24

Review 10.  Thyroid and Cardiovascular Disease: A Focused Review on the Impact of Hyperthyroidism in Heart Failure.

Authors:  Rafay Khan; Saad Sikanderkhel; Junhong Gui; Abdul-Razaq Adeniyi; Kimberly O'Dell; Marc Erickson; Juan Malpartida; Zarmina Mufti; Taiba Khan; Harris Mufti; Saif Aldeen Al-Adwan; Diana Alvarez; Joshua Davis; Joseph Pendley; Dharmendra Patel
Journal:  Cardiol Res       Date:  2020-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.